General Information about IBUS Group

In recent times, technological advances in ultrasonography have enabled new scopes of practice in gastroenterology. Today, ultrasound is invaluable as both a diagnostic tool and as a means of guiding treatment in patients with inflammatory bowel disease (IBD). Despite these attributes, gastrointestinal ultrasonography (GIUS), as a service provision and standard of care, is relatively sparsely established.

As a result, in the year 2016, a group of leading international clinicians and scientists created an organization with the aim of representing new imaging diagnostics, namely gastrointestinal ultrasound, on the international stage and to advance its use in a clinical and research setting.

IBUS Mission

As a non-profit organization, IBUS aims to advance GIUS research, education and clinical applicability in the area of IBD. This is to ultimately improve personalised patient care and help contribute to management decisions and patient outcomes.

IBUS Objectives

  • To promote, sponsor and steer international research efforts in the field of GIUS in IBD.
  • To cooperate and collaborate with other organisations that share an interest in the field of GIUS in IBD, including medical societies and companies.
  • To enhance the quality of research in the field of IBD, in both basic science and clinical science (e.g. through the development of IBD study protocols).
  • To facilitate and promote the education of health care professionals in the field of GIUS in IBD.
  • To organise international and regional scientific or educational exchange programmes in the field of GIUS in IBD.
  • To influence the management of IBD through developments, publications, dissemination and teaching of IBD guidelines and other educational material.
  • To be transparent about IBUS governance, structure, activities, finances and all other IBUS operational matters; thereby ensuring that information is readily available to IBUS Members and the medical, scientific and academic community.